Biotech Resources Group | GMP Capacity Advisors
IS YOUR GMP CAPACITY THE NEW CRITICAL PATH? GMP IS IN OUR DNA®
Biotech Resources Group (BRG) helps GMP biologics companies make better manufacturing decisions when it matters most—whether you:
Build new capacity
Optimize an existing facility
Buy capacity from a CDMO

Video can’t be displayed
Video can’t be displayed
Let's put pencil-to-paper with our GMP Services Ecosystem. Our services ecosystem is called BRIDGEONE.
Biotech Resources Group helps you choose the right path, or the right mix, and carry it out with strict GMP Rigor.
OPTIMIZE: Get more from what you already have. We find and remove the hidden constraints in your current operations, including throughput, changeovers, quality systems, release and right-first-time performance, so you gain capacity without new walls. Do this step first.
UPSIDE: Defer CapEx and CDMO spend.
BUILD: Create capacity you control. Facility strategy, design, engineering and readiness for new or expanded GMP operations, from concept through qualification and inspection readiness.
BUY: Secure capacity through the right partners. We provide CDMO and supplier strategy, selection, due diligence and tech-transfer readiness, so outsourced capacity is reliable, compliant and aligned with your timelines.
BRIDGEONE
3 GMP Capacity Levers:
Optimize, Build and/or Buy
"Resolving capacity-specific pain-points significantly lowers internal tension, fostering a more collaborative and productive work environment."
- Susan & Bob Valdes
BRG: BY THE NUMBERS
FOUNDERS' EXPERIENCE: 50+ yr
NETWORK'S COLLECTIVE EXPERIENCE: 200+ yr
GMP DIVISION FOUNDED: 2011
RECRUITING DIVISION FOUNDED: 2000
PROJECT GEO: 6 CONTINENTS
FACILITIES: 20+
MODALITIES: 5+
CDMO/INNOVATOR/HYBRID: ALL
REQUISITE A.I. GOVERNANCE: YES
HOSTS: 4DS/DP: YesE-BOOKS: 2+PLAYBOOKS: 3SCI JOURNAL PAPERS: 1TRADEMARKS: 3
SERVICE LANES: 3
NETWORK: GLOBAL
LANGUAGES: 6
Human Expertise &
Clear A.I. Boundaries
At Biotech Resources Group, you engage human expertise —
not A.I.-generated reports.
Our A.I. Use, Human Authorship & Content Integrity Policy requires qualified, named experts to develop every report’s framework, narrative, analysis, and recommendations.
We permit approved A.I. tools only for defined support tasks, with disclosure and human verification, and prohibit entering confidential client information into tools not approved for that data classification.
Sources are personally checked, authors remain accountable, and deliverables undergo documented review.
For our clients, that means clear boundaries around A.I. use, safeguards for sensitive information, and advice grounded in professional judgment—not purely automated synthesis.
Our A.I. Policy document is shared
during CDA execution.
© Copyright 2026
Biotech Resources Group, LLC
☎ -+1--617.858.033.two---
☎ -+1--202.738.338.six---
GEO USA, EU, APAC
WEB www.biotech-1.com
𐀪 Robert & Susan Valdes
✉ bobv@biotech-1.com
🏠︎1 Washington, D.C. Metro Area
Build - Optimize - Buy ©
GMP IS IN OUR DNA®
GMP IS IN OUR pDNA®
GMP IS IN OUR mRNA®
LinkedIn www.linkedin/in/gmp1